000
| 01007nam##2200265za#4500 |
---|
001 | 9.577182 |
---|
003 | CaOODSP |
---|
005 | 20210624185506 |
---|
007 | cr ||||||||||| |
---|
008 | 150406|1997||||xxc|||||o f|0| 0 eng|d |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH42-2/4-1997-1E-PDF |
---|
110 | 1 |aCanada.|bHealth Canada. |bTherapeutic Products Programme. |
---|
245 | 10|aInclusion of women in clinical trials |h[electronic resource] |
---|
250 | |aFinal version |
---|
260 | |aOttawa - Ontario : |bHealth Canada. |cApril 17, 1997. |
---|
300 | |a5p. |
---|
490 | 1 |aTherapeutic Products Programme guideline |
---|
590 | |a13-19-Supp|b2013-08-14 |
---|
690 | 07|aPharmaceutical industry|2gcpds |
---|
690 | 07|aWomen|2gcpds |
---|
775 | 08|tInclusion des femmes dans les essais cliniques |w(CaOODSP)9.605991 |
---|
830 | #0|aTherapeutic Products Programme guideline.|w(CaOODSP)9.507557 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s22 KB|uhttps://publications.gc.ca/collections/collection_2013/sc-hc/H42-2-4-1997-1-eng.pdf |
---|